Le Lézard
Classified in: Health
Subject: PDT

Sysmex Offers US Labs More Customized And Scalable Options With XN-9100 And XN-3100 Hematology Automation Systems



LINCOLNSHIRE, Ill., Oct. 5, 2017 /PRNewswire/ -- Sysmex America, Inc. announced today that it is introducing two hematology automation systems that will provide laboratories in the United States with more customized, scalable and efficient operations. The XN-9100 and XN-3100 automation technology combines the unified mechanization of prior models with new features offering greater laboratory customization and scalability. Of particular note, both systems integrate with the new SP-50, 5th-generation slidemaker-stainer further, enhancing automation that can promote consistency while increasing laboratory efficiency.

Sysmex America, Inc. Logo. (PRNewsFoto/Sysmex America, Inc.) (PRNewsFoto/)

"Sysmex's new range of automation is designed to meet the increasing demands faced by our customers, to be even more productive in the space and with the resources available to them," said Andy Hay, Chief Operating Officer. "The XN-9100 and XN-3100 build on our best-in-class hematology analyzers, offering the reliability, precision and diagnostic innovation that clinicians value, and have come to depend on from Sysmex."

XN-9100

Dynamic, high-volume and growing labs seeking greater flexibility in instrument form and function will find it in the XN-9100. The new system provides the same reliable and proficient connectivity options as the XN-9000, but with greater customization that saves space and maximizes productivity.

The XN-9100's many features and benefits include:

XN-3100

The XN-3100 is a compact benchtop unit. With an optional wagon for greater storage and easy reagent access and replenishment, it is a perfect solution for lower to mid-volume testing facilities. With two XN analyzers processing samples simultaneously, the throughput is consistently high and delivers the advanced clinical parameters larger volume labs have come to rely on.

The XN-3100's many features and benefits include:

The new XN-9100 and XN-3100 systems are available directly through the company. Interested parties are asked to contact their Sysmex representative or Sysmex distributor for complete details. Additional information is available on the company's website, https://www.sysmex.com/us/en/Pages/default.aspx.

About Sysmex America
Sysmex America, Inc. distributes and supports a diverse portfolio of best-in-class, in vitro diagnostic hematology and clinical laboratory products in the U.S., Canada and Latin America. It is the U.S. regional office of Sysmex Corporation, a trusted world leader in clinical laboratory solutions that optimize efficiency, operations and financial performance in the lab, located in Kobe, Japan. Sysmex is reshaping the healthcare of tomorrow at the clinical laboratory level by transcending the boundaries of diagnostic science and serving as the pulse of reliable, accountable care. For more information about Sysmex America, visit www.sysmex.com/us.

 

SOURCE Sysmex America, Inc.


These press releases may also interest you

at 17:01
The Elizabeth Dole Foundation commends Congress for passing the Recognize, Assist, Include, Support, and Engage (RAISE) Family Caregivers Act today. The Foundation, which has fought for passage of this bill over the past two years, is pleased to see...

at 17:00
The global market for process analytical technologies (PAT) in pharmaceuticals should reach $412.7 million in 2017 and nearly $539.3 million by 2022 at a compound annual growth rate (CAGR) of 5.5% for the period of 2017 to 2022. Read the full report:...

at 16:57
PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device and diagnostics industries, has named Deloitte Digital's life sciences agency as one of the most innovative divisions of 2017....

at 16:46
The global market for healthcare cloud computing should reach $20.2 billion in 2017 and $35.0 billion by 2022, growing at a compound annual growth rate (CAGR) of 11.6% during 2017-2022. Read the full report: https://www.reportlinker.com/p05251939 ?...

at 16:45
Organigram Holdings Inc. (the "Company" or "Organigram"), a leading producer of medical marijuana, is pleased to announce that it has entered into a Letter of Intent ("LOI") with Farm Credit Canada ("FCC") for a loan in the amount of $10 million....

at 16:45
Parker Waichman LLP lauds the efforts of Dr. Michael Crane to focus attention on the difficulties faced by those seeking benefits related to the 9/11 tragedy. Despite state and federal laws authorizing the screening and medical coverage for survivors...




News published on 5 october 2017 at 13:09 and distributed by: